BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11579502)

  • 1. [Splenectomy in 5 patients with idiopathic myelofibrosis].
    Nozato A; Mizorogi F; Fukumi S; Watanabe H; Kobayashi M
    Rinsho Ketsueki; 2001 Aug; 42(8):627-32. PubMed ID: 11579502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
    Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
    Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of splenectomy in the treatment of myelofibrosis].
    Melikian AL; Kolosova LIu; Sokolova MA; Kovrigina AM; Silaev MA; Giliazitdinova EA; Gemdzhian ÉG; Karagiulian SR
    Ter Arkh; 2013; 85(8):69-76. PubMed ID: 24137967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy for myelofibrosis.
    Järvinen H; Kivilaakso E; Ikkala E; Vuopio P; Hästbacka J
    Ann Clin Res; 1982 Apr; 14(2):66-71. PubMed ID: 7149614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.
    Lafaye F; Rain JD; Clot P; Najean Y
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
    Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
    Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
    Akpek G; McAneny D; Weintraub L
    J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Splenectomy in idiopathic thrombopenic purpura and in myelofibrosis. A retrospective study of platelet increase, hemorrhagic complications and mortality].
    Hellström P; Ogier C; Askergren J; Sundblad R; Reizenstein P
    Minerva Chir; 1981 Sep; 36(17):1065-8. PubMed ID: 7197336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
    Faoro LN; Tefferi A; Mesa RA
    Eur J Haematol; 2005 Feb; 74(2):117-20. PubMed ID: 15654901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide for the treatment of idiopathic myelofibrosis.
    Strupp C; Germing U; Scherer A; Kündgen A; Mödder U; Gattermann N; Haas R
    Eur J Haematol; 2004 Jan; 72(1):52-7. PubMed ID: 14962263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell transplantation for myelofibrosis: a report from two Canadian centers.
    Daly A; Song K; Nevill T; Nantel S; Toze C; Hogge D; Forrest D; Lavoie J; Sutherland H; Shepherd J; Hasegawa W; Lipton J; Messner H; Kiss T
    Bone Marrow Transplant; 2003 Jul; 32(1):35-40. PubMed ID: 12815476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A
    Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
    Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
    Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP).
    Schwartz J; Leber MD; Gillis S; Giunta A; Eldor A; Bussel JB
    Am J Hematol; 2003 Feb; 72(2):94-8. PubMed ID: 12555211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic myelofibrosis: a retrospective study of 103 patients.
    Anger B; Seidler R; Haug U; Popp C; Heimpel H
    Haematologica; 1990; 75(3):228-34. PubMed ID: 2227619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allogeneic bone marrow transplantation for primary myelofibrosis after splenectomy].
    Sakashita C; Akiyama H; Mori S; Ohashi K; Sakamaki H
    Rinsho Ketsueki; 2000 Mar; 41(3):206-11. PubMed ID: 10774249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
    Randi ML; Fabris F; Ruzzon E; Pacquola E; Cella G; Girolami A
    Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.